• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Interviews»Interviews - Industry»Prominent Virologist Prof. Guntaka V Ramareddy joins Advisory Board of Biotech Express
Prof Guntaka Ramareddy (right) with Dr APJ Abdul Kalam (left)

Prominent Virologist Prof. Guntaka V Ramareddy joins Advisory Board of Biotech Express

0
By Biotech Express on June 14, 2021 Interviews - Industry

Prof Guntaka was first scientist who introduced recombinant biotech drugs in India by making Hep-B  vaccine for Shantha biotech company in 1990s. Now he is running his company Sudarshan Biotech and is involved in the discovery of Hep-C vaccine which is not available anywhere in the world.

It is a privilege to have Dr. Ramareddy in the Advisory Board of Biotech Express magazine. Biotech Express welcome Prof Guntaka on its editorial board and we believe his accord will be much useful in current viral pandemic times.

Prof Ramareddy V Guntaka
Current Affiliations: Chairman and Chief Scientist, Sudarshan Biotech Pvt Ltd., TSIIC Park, Nacharam, Hyderabad, India & Emeritus Professor, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Dr. Ramareddy’s research background is in the field of Microbiology and he is an outstanding vaccine researcher who was the chief scientific resource in the success of India’s first biotechnology company i.e. Shantha Biotech.

He earned his Ph.D in Microbiology from Kansas State University, Manhattan in (1970). He was graduated with B.Sc in Chemistry and Biology, A.N.R. College, Gudivada, India and got his M.Sc in Microbiology from U.P. Agricultural University, Pantnagar, U.P., India (1965).

To use his expertise in the field of virology which is utmost importance in this current pandemic, we decided to invite him as an advisory member of board which Prof Guntaka has agreed to join. To give more  information to readers about his thinking process we posed some questions to get his vision and mission. These can be framed as following:

Q1. Sir how are you planning to contribute to this magazine?
Through Biotech Express we can provide information to the public on various issues related to health, state of the art developments in science and Technology etc. Up to date information on the COVID pandemic and the efficacy of various available vaccines which is vital for the citizens of India.

Q2. Sir what are your prime focus now after Hep-B?
Our primary focus is to bring vaccine for Hepatitis C and bring high value therapeutics at an affordable price. Many antigens used in the diagnostic kits are not made in India; most of these are currently imported. We already have several of them at Sudarshan Biotech and now we can market them.

Q3. Sir, what are your suggestions to scientific community which is involved in this current COVID-19 pandemic?
COVID-19 pandemic is an unusual disease. As everybody is aware, it is affecting all the age groups, although more devastating to the elderly and people with pre-existing health conditions. As an scientist we may look at vaccines and drugs that are more safe and efficient, healthcare workers may use more precautions to get away from infection and govt. may use data statistics to make more robust guidelines. For example, I have discussed earlier through this magazine that how we can avoid lockdowns which is subsequently affecting huge population and leading to unemployment and sufferings.

Q. What is your company Sudarshan biotech is manufacturing and what are future goals of this biotech company now?
Until recently Sudershan Biotech was located in a residential area and we are not allowed to manufacture any biotech products. Now we have relocated to Nacharam where we can manufacture. Sudershan Biotech is a Research oriented company and we have several patents including Hepatitis C virus sequence, Human Serum Albumin in Pichia pastoris, therapeutics like Interferon beta1a and 1b in E. coli. Soon we will start producing these and start clinical trials. We will also produce antigens for Hepatitis B and Hepatitis C viruses as well as Human Immunodeficiency virus.

Prof Guntaka Ramareddy has received many honors and awards like Government of India Merit Scholarship, 1963-1965; American Cancer Society Senior Dernham Fellowship, 1973-1975; Research Career Development Award from National Institutes of Health 1979-1984 and many others.

He has been appointed in various positions like Associate Professor, Department of Microbiology, School of Medicine, University of Missouri, Columbia; Assistant Professor, Department of Microbiology, College of Physicians and Surgeons, Columbia University; Assistant Research Microbiologist, University of CaIifornia, San Francisco. In his research career he has published over 110 research papers in reputed journals including Nature and also holds a patent.

Among the discovery of Hep B vaccine his other outstanding pioneer contributions are:
1. First group (with Bishop and Varmus) to show that retrovirus DNA replication occurs in the cytoplasm and then in the nucleus of infected cells and to show accumulation of supercoiled DNA in the nuclei of retrovirus-infected cells.
3 First group (Shank, Bishop, Varmus; Taylor) to demonstrate the presence of Long Terminal Repeats (LTRs) at the ends of retroviral DNA.
4. First group (with Stehelin, Bishop, Varmus) to discover proto-oncogenes.
5. First one to clone an infectious Rous sarcoma virus DNA (Walter Gilbert’ group sequenced this clone).
6. First to show methylation of provirus in non-permissive cells.
7. Demonstrated formation of triplexes of Triplex-forming oligonucleotide with the collagen gene promoter (resulted in a patent assignment to Guntaka).
8. First group to sequence the Indian strain of Hepatitis C Virus.

Last Updated on June 20, 2021

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Interview: How to approach COVID-19 as biopreneur? Talk with Dr Ram S Upadhayaya

Interview – Women Achievers in Biotechnology – Dr. Poonam Sharma, Director, Gyan Bindu Academy Pvt. Ltd.

Interview – Ready to make big changes in Biopharma industry through Stem Cell applications – Dr Subhadra Dravida, Founder, Transcell

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.